| 128-13-2 |
Ursodeoxycholic acid |
3,7-Dihydroxycholan-24-oic acid; 3alpha,7beta-Dihydroxy-6beta-cholan-24-oic acid; Ursodiol; 2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethanol; (3alpha,5beta,7alpha)-3,7-dihydroxycholan-24-oic acid; (3alpha,5beta,7beta)-3,7-dihydroxycholan-24-oic acid; (4R)-4-[(3R,5S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid; (4R)-4-[(3R,5S,7S,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid; (3alpha,5beta,7beta,8xi,9xi,14xi)-3,7-dihydroxycholan-24-oic acid; (3alpha,5beta,7beta)-3,7-dihydroxycholan-24-oate; (3alpha,5alpha,7beta)-3,7-dihydroxycholan-24-oate |
C24H39O4 |
52
supplier(s)
128-13-2 |
| 136434-34-9 |
N-Methyl-gama-(1-naphthalenyloxy)-2-thiophenepropanamine |
(S)-DULOXETINE HYDROCHLORIDE;LY-248686;DULOXETINE HCL;DULOXETINE HYDROCHLORIDE;N-methyl-gamma-(1-naphthalenyloxy)-2-thiophenepropanamine, hydrochloride;(RS)Duloxetine HCl;(+)-(S)-N-Methyl-g-(1-naphthyloxy)-2-thiophenepropylamine;(gS)-N-Methyl-g-(1-naphthalenyloxy)-2-thiophenepropanamine |
C18H20ClNOS |
16
supplier(s)
136434-34-9 |
| 100-00-5 |
1-Chloro-4-nitrobenzene |
p-Nitrochlorobenzene; 4-Nitrochlorobenzene; P-Nitro chloro benzene; p-chloronitrobenzene; 4-Chloronitrobenzene; N,N,4-trimethylaniline |
C6H4ClNO2 |
5
supplier(s)
100-00-5 |
| 1427-07-2 |
2-Fluoro-4-nitrotoluene |
2-Fluor-1-methyl-4-nitrobenzol; 2-Fluoro-1-methyl-4-nitrobenzene; Benzene, 2-fluoro-1-methyl-4-nitro-; Toluene, 2-fluoro-4-nitro- |
C7H6FNO2 |
7
supplier(s)
1427-07-2 |
| 187947-37-1 |
AA-5-HT |
N-ARACHIDONYL-5-HYDROXYTRYPTAMINE;N-[2-(5-HYDROXY-1H-INDOL-3-YL)ETHYL]-5Z,8Z,11Z,14Z-EICOSATETRAENAMIDE;ARACHIDONYLSEROTONIN;ARACHIDONOYL SEROTONIN;AA-5-HT;AA-5-HT, N-[2-(5-Hydroxy-1H-indol-3-yl)ethyl]-(5Z,8Z,11Z,14Z)-5,8,11,14-Eicosatetraenamide;N-Arachidonoylserotonin;N-[2-(5-Hydroxy-1H-indol-3-yl)ethyl]-5,8,11,14-eicosatetraenamide |
C30H42N2O2 |
13
supplier(s)
187947-37-1 |
| 100-11-8 |
4-Nitrobenzyl bromide |
alpha-Bromo-4-nitrotoluene; 4-Nitrobenzyl bromide/a-Bromo-4-Nitrotoluene; 4-Nitrobenzyl bromide,(a-Bromo-4-nitrotoluene); 3,5-Dinitrobenzyl chloride; 1-(Bromomethyl)-4-nitrobenzene; P-Nitrobenzyl bromide; 4-(bromomethyl)nitrobenzene; alpha-Bromoparanitrotoluene |
C7H6BrNO2 |
3
supplier(s)
100-11-8 |
| 163222-33-1 |
Ezetimibe |
1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-hydroxy-propyl]-4-(4-hydroxyphenyl)-azetidin-2-one;EZETIMIBE;ZETIA;Ezitimibe∬EzetimibeC24H21F2N03;(3R,4S)-1-(4-Fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone, Sch-58235;1-(4-Flurophenyl)-(3R)-3-(4-flurophenyl)-(3S)-hydroxypropyl-(4S)-(4-hydroxyphenyl)-2-azetidinone;Ezetimide |
C24H21F2NO3 |
29
supplier(s)
163222-33-1 |
| 147526-32-7 |
Pitavastatin calcium |
(+)-Monocalciumbis{(3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydroxy-6-heptenoate}; calcium bis{(1R,3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-1,3,5-trihydroxyhept-6-en-1-olate}; (+)-Monocalciumbis{(3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-,5-dihydroxy-6-heptenoate} |
C50H48CaF2N2O8 |
18
supplier(s)
147526-32-7 |
| 100-02-7 |
4-Nitrophenol |
P-Nitro phenol; P-Nitrophenol; 4-nitrophenolate |
C6H5NO3 |
11
supplier(s)
100-02-7 |
| 1405-10-3 |
Neomycin Sulphate |
mycifradin sulfate; o-2,6-diamino-2,6-dideoxy-.beta.-l-idopyranosyl-(1.->3)-o-.beta.-d-ribofuranosyl-(1->5))-o-(2,6-diamino-2,6-dideoxy-.alpha.-d-glucopyranosyl-(1->4))-2-deoxy sulfate; Neomycin Sulfate; (1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside sulfate (1:1); (2S,3S,4S,5S,6S)-5-amino-2-(aminomethyl)-6-[(1S,2S,3S,4R,6R)-4,6-diamino-2-[(2R,3S,4R,5S)-4-[(2S,3S,4S,5S,6R)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol; sulfuric acid; Nystatin sulfate |
C23H48N6O17S |
23
supplier(s)
1405-10-3 |
Pharma Sources Insight January 2025
